NCT00863161View on ClinicalTrials.gov

Renal Impairment Study

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

RefluxRenal Excretion

Interventions

DRUG

AZD3355

capsule, oral, single dose

Trial Locations (3)

Unknown

Research Site, Linköping

Research Site, Luleå

Research, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY